Stocks and Investing Stocks and Investing
Fri, July 21, 2023

David Lewis Reiterated (ABT) at Hold and Held Target at $112 on, Jul 21st, 2023


Published on 2024-10-28 05:00:47 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Reiterated "Abbott Laboratories" (ABT) at Hold and Held Target at $112 on, Jul 21st, 2023.

David has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with David


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $123 on, Thursday, April 20th, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Thursday, April 20th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $127 on, Thursday, April 20th, 2023
  • Matthew Korn of "UBS" Maintained at Strong Buy with Increased Target to $130 on, Thursday, April 20th, 2023
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Increased Target to $130 on, Monday, April 17th, 2023
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $136 on, Monday, April 10th, 2023
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $136 on, Wednesday, April 5th, 2023
  • Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $117 on, Wednesday, March 29th, 2023

Contributing Sources